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The CBCT step was eliminated which streamlined the clinical 
protocol as CBCT verification is limited to couch zero. The 
treatment time was reduced by 5-7 minutes per fraction and 
the dose at the verification step reduced from c.72mGy to c. 
0.335mGy (AAPM TG 75). Patient intrafraction data was 
benchmarked against the 1mm accuracy delivered by the 
conventional frame based radiosurgery. The results 
demonstrate that this criteria was met, with all translational 
errors well below 1mm and rotational errors below 
0.5degrees which we use as the online tolerance for 
treatment delivery (Table 1). 
  
 
 
Conclusions: As per previous studies a modest difference 
between ET x-ray and CBCT corrections was found in patient 
data but not in phantom testing, even though in this study 
both sets of images were analyzed with six degrees of 
freedom in the Brainlab software. The difference is due to 
inherent differences in the modalities, as it cannot be fully 
accounted for by intrafraction motion. The imaging strategy 
was optimized and streamlined, informed by the quantified 
stability of the masking system and the optimum positioning 
verification modality for cranial SRS procedures. 
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Purpose/Objective: Radical radiotherapy with hypo-
fractionated (HF) regimen is used in some busy centres for 
the treatment of early glottic cancers (EGC). We at our 
centre conducted an audit of the EGC treated with HF 
regimen and analysed the factors impacting local control. 
Materials and Methods: 59 unselected patients of 
histologically confirmed glottis squamous cell cancer patients 
treated during September 2011 to July 2014, were analysed. 
Only patients with stage T1/ T2 N0 as per the 7th edition of 
AJCC and who were treated using a HF regimen of 5500cGy 
delivered in 20 were included. Only patients with a minimum 
follow up of six months, n=56, were analysed. The outcomes 
and treatment as well as tumour related factors associated 
were systematically analysed and correlated to outcome. We 
also did an audit of the online matching of the carotid 
sparing (CS) cohort to analyse the importance of residual 
errors and its impact on local control. 
Results: This analysis was done at a median follow up of 18 
months. 89.3% of the patients were T1 and 10.7% were T2. 
57.1% patients were treated using IMRT (93.8% helical 
tomotherapy (HT) and 6.2% VMAT), the remaining were 
treated using 3DCRT. 18 patients in the IMRT group had 
undergone carotid sparing (CS) as part of a prospective study. 
A bolus was required for dose build up in the anterior 
commissure (AC) region in 72.7% patients with a risk of 
involvement to that area. All patients achieved a complete 
response at the first post radiation visit 4-6 weeks post 
therapy. 7 patients had grade 2 or more dermatitis.15 
patients (26.8%) developed grade 2 or more dysphagia. 
Overall 10.7% patients had failure of treatment with 5 
patients having a local recurrence and 1 patient failing 
regionally in the nodal region. One patient died of an 
unrelated medical condition. Clinical stage did not have any 
significant bearing on the control rates (T1a vs T1b vs T2 8.6% 
vs 13.3% vs 16.7%; p=0.8). All failures occurred in the IMRT 
group with 10.7% failures overall and 18.7% within the group. 
All failures occurred in the HT IMRT arm (5/6 had disease 
involving AC, anterior cord (1/6)). CS was significantly 
associated with failure with 5/6 recurrence occurring in this 
group (p=0.005). The PTV indices D99 (p=0.01), D50 (p=0.001) 
and HI (p=0.004) were significantly better in those who 
failed. Other treatment related factors like the AC 
involvement, prolongation of the duration of radiation course 
did not have significant relation with the outcome. Also the 
online matching of the patients who had undergone CS was 
done to analyse the impact of errors in matching. Residual 
errors were calculated for these patients based on the offline 
matching shift data. None of the residual translational errors 
turned out to be significantly related to recurrence in the 18 
patients in the carotid spared group. 
Conclusions: Hypofractionated radiotherapy is safe with 
acceptable toxicity rates and good overall control. However 
in tumors with anterior extension there may be higher chance 
of failure. Good image guidance protocols with proper 
placement and matching of bolus is very important. 
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Purpose/Objective: 4D-CBCT provides the potential for 
significant improvements in patient treatment, but must be 
smoothly integrated into the clinical workflow both to 
optimize the treatment process for the patient and to ensure 
patient safety. Following the installation of 4D-CBCT an 
implementation process and preliminary clinical evaluation of 
4D-CBCT has been performed. A multi-professional team has 
been involved in the implementation and evaluation process.  
Materials and Methods: 4D-CBCT scans have been acquired 
on patients planned using 4D-CT (p4D-CT) data over a 12-
month period. A process was developed for the on-line 3D-
CBCT registration, 4D-CBCT retrospective reconstruction and 
viewing of 4D-CBCT image data in comparison with p4D-CT 
image data. All steps in the process were evaluated to 
develop a method integrated with the RTT’s clinical linac 
workflow. This included image acquisition, reconstruction 
and assessment of image quality. To assist with patient 
selection for 4D-CBCT and departmental resource restrictions 
the tumour motion on p4D-CT data was compared to 4D-CBCT 
treatment data and any changes in tumour motion, size or 
position noted. 
Results: 4D-CBCT scans were acquired on 60 conventionally 
fractionated lung, 62 SABR lung, 33 oesophagus, 4 expiration 
gated lung, 1 SABR liver and 3 abdominal patients. The total 
number of 4D-CBCT scans was 411. The 4D-CBCT 
reconstruction time of 3 min is quick enough for near online 
image review but is not feasible with the patient on the 
treatment couch in a busy department. Treatment RTTs 
required additional training for the data export and 
reconstruction processes and a training package has been 
written. Image quality is felt to be acceptable for verification 
purposes of thoracic tumours. There is a requirement to 
optimise the 4D-CBCT acquisition parameters to improve 
image quality for abdominal tumours. 2 patients were re-
planned based on the assessment of tumour motion on the 
4D-CBCT data compared to the p4D-CT data. For other 
patients, 4D-CBCT was a useful tool to verify tumour motion 
between planning and treatment. It was especially useful for 
gated patient verification where the relationship between 
the external surrogate and tumour motion may change 
between planning and treatment.  
Conclusions: It is beneficial to utilise 4D-CBCT to verify any 
lung treatment involving anatomical motion due to 
respiration, whether a respiratory gated treatment is used or 
not. 4D-CBCT is felt to be essential for the verification of 
gated treatments and may enable an increased number of 
patients to receive a gated treatment as it may remove the 
reliance on the tumour being visible on fluoroscopy. We are 
continuing to optimise imaging modes for abdominal 4D-CBCT 
scans and clinical applications. A training program has been 
developed for RTTs to perform the evaluation of the 4D-CBCT 
image data and is fully integrated into the routine clinical 
workflow. 
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Purpose/Objective: A 2D ultrasound (US) probe has recently 
being applied as a tool for image guided radiotherapy (IGRT), 
despite reported challenges in the probe handling. The aim 
of this study was to investigate a novel 3D-US probe against 
the conventional 2D probe for gynecological (GYN) IGRT. 
Materials and Methods: 9 healthy volunteers were US-
scanned by 6 operators (RTTs), using both 2D and 3D probes 
(Clarity® Model 310C00, Elekta, Montreal, Canada) (see 
figure). 
  
 
In total, 38 US-scans were performed. Two observers 
(Physicist and RTT) were evaluating the image quality, and, 
independently, delineated the uterus on all scans. The image 
quality was classified from 1-10, where 10 was perceived as 
excellent. Furthermore, the uterus in the acquired images 
was divided in 4 sections. This scale was introduced to, 
quantitatively, evaluate the capacity of each probe in 
capturing the whole uterine volume. For instance, 4 uterine 
visible sections was indicating capture of entire uterus and 2 
sections, on the other hand, means that half of the uterine 
volume is imaged. 
Results: Using the 2D probe yielded a mean image quality of 
5.4 (mean of 38 scans and two observers). The 3D probe 
resulted in a mean of 7.2, implying a better image quality. 
Furthermore, uterine capture using the 2D and the 3D probe 
resulted in a mean of 2.9 and 3.6, respectively. All observers 
were concordant in preferring the 3D-probe over the 2D-
probe images for uterine delineation, due to better image 
quality. Secondly, the uterine capture was readily achievable 
using the 3D probe as compared to the 2D probe. 
Furthermore, during image acquisition, the 2D probe required 
a manual handling, known as sweep slide-technique, which 
was experienced to be challenging for all the RTTs. Inversely, 
the 3D probe is a semi-automatic imaging system, meaning 
that the images could be acquired by initially identifying the 
